Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 325,422 | reported | 01 Jan 2026 | tx 33+8,827,300−2,286,712 |
| Invivyd, Inc. | 35,593 | reported | 05 Aug 2021 | tx 1+35,593 |
| X4 Pharmaceuticals, Inc | 6,000 | reported | 02 Jun 2021 | tx 4+172,854 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 44,250 | — | |
| 31 Dec 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 1,500,258 | 0.00 USD | deriv |
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 44,250 | 0.00 USD | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 150,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 350,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 473,334 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 239,703 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 239,703 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 2,075,000 | 0.00 USD | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 473,334 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 135,134 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 135,134 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 50,041 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 50,041 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 100,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 100,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 350,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 700,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 700,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 150,000 | — | deriv |
| 16 Jun 2025 | PURCHASE | Xilio Therapeutics, Inc. | 36,289 | 0.68 USD | |
| 15 Apr 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 190,000 | 0.00 USD | deriv |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 44,250 | — | |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 44,250 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 638,000 | 0.00 USD | deriv |